UBA6

Chr 4

ubiquitin like modifier activating enzyme 6

Also known as: E1-L2, MOP-4, UBE1L2

Modification of proteins with ubiquitin (UBB; MIM 191339) or ubiquitin-like proteins controls many signaling networks and requires a ubiquitin-activating enzyme (E1), a ubiquitin conjugating enzyme (E2), and a ubiquitin protein ligase (E3). UBE1L2 is an E1 enzyme that initiates the activation and conjugation of ubiquitin-like proteins (Jin et al., 2007 [PubMed 17597759]).[supplied by OMIM, Mar 2008]

OMIMResearchGenerating clinical summary…
LOEUF 0.56
Clinical SummaryUBA6
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.56LOEUF
pLI 0.000
Z-score 4.43
OE 0.40 (0.290.56)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.10Z-score
OE missense 0.87 (0.800.94)
461 obs / 532.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.40 (0.290.56)
00.351.4
Missense OE?0.87 (0.800.94)
00.61.4
Synonymous OE?0.94
01.21.6
LoF obs/exp: 26 / 64.3Missense obs/exp: 461 / 532.3Syn Z: 0.64

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

UBA6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →